Medicine guide
IMJUDO
As listed in the register: IMJUDO 20 mg/ml, solution à diluer pour perfusion
20 mg · solution à diluer pour perfusion
- Prescription only
- Active substance
- Trémélimumab
- Made by
- ASTRAZENECA AB
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | ASTRAZENECA AB |
|---|---|
| Active substance | Trémélimumab |
| Strength | 20 mg |
| Form | solution à diluer pour perfusion |
| Route | intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/22/1713 |
| Name in the register | IMJUDO 20 mg/ml, solution à diluer pour perfusion |
| Packs | 1 flacon en verre de 15 mL |
| CIS | 68577115 |
| CIP13 | 3400955094579 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).